EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Lars Sondergaard
Lars Sondergaard, Denmark, is an Interventional Cardiologist who works exclusively with structural interventions and who has extensive experience with TAVI. Having originated the TAVI programme in Copenhagen back in 2007 (<1000 procedures to date), Lars Sondergaard is the PI for the NOTION 1 and NOTION 2 trials which are comparing TAVI and surgical aortic valve replacement in younger, low-risk patients.
“We have evidence that TAVI is a safe and efficient treatment for these groups. I look forward to seeing you in Paris for the Great Debate.“